Cardiovascular and Kidney Effects of Glucagon-Like Peptide 1 Receptor Agonists
KEY POINTS • GLP-1RAs lower MACE by around 14% to 15% overall with broadly consistent benefits across its constituents’ outcomes, including CV death. • Three drugs in the class—liraglutide, semaglutide,…
read more
